| |
 |
|
Class Information
Number: 514/183
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai
Description: Subject matter which includes a compound containing a ring composed of carbon and at least one element from the group consisting of nitrogen, sulfur, selenium, tellurium and oxygen as DOAI.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 514/184 |
Heavy metal containing (including salts) |
555 |
| 514/191 |
Aluminum (including salts) |
54 |
| 514/192 |
1-thia-4-aza-bicyclo (3.2.0) heptane ring containing (including dehydrogenated) (e.g., penicillins, etc.) |
269 |
| 514/200 |
1-thia-5-aza-bicyclo (4.2.0) octane ring containing (including dehydrogenated) (e.g., cephalosporins, etc.) |
180 |
| 514/210.01 |
Hetero ring is four-membered and includes at least one ring nitrogen |
166 |
| 514/211.01 |
Hetero ring contains seven members including nitrogen, carbon and chalcogen |
167 |
| 514/212.01 |
Hetero ring is seven-membered consisting of one nitrogen and six carbons |
229 |
| 514/218 |
Hetero ring is seven-membered consisting of two nitrogens and five carbon atoms |
853 |
| 514/222.2 |
Hetero ring is six-membered and includes at least nitrogen and sulfur as ring members |
166 |
| 514/228.8 |
Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) |
265 |
| 514/241 |
Hetero ring is six-membered consisting of three nitrogens and three carbon atoms |
587 |
| 514/247 |
Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) |
741 |
| 514/277 |
Hetero ring is six-membered consisting of one nitrogen and five carbon atoms |
864 |
| 514/359 |
Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) |
597 |
| 514/430 |
Sulfur containing hetero ring |
107 |
| 514/449 |
Oxygen containing hetero ring |
562 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6274610 |
Acyl mercapto-triazolyl derivatives and the use thereof as microbicides |
Aug. 14, 2001 |
| 6274619 |
Amidino substituted tetrahydrobenzo thiophene or furan derivatives and their use as urokinase inhibitors |
Aug. 14, 2001 |
| 6271257 |
Decreasing the intracellular level of .beta.-catenin by administering hydroxymatairesinol |
Aug. 7, 2001 |
| 6271264 |
Polymers containing spirobicyclic ammonium moieties as bile acid sequestrants |
Aug. 7, 2001 |
| 6268352 |
Promoters of neural regeneration |
Jul. 31, 2001 |
| 6264966 |
Compounds with chelation affinity and selectivity for first transition elements and their use in cosmetics and personal care products, inhibition of metalloenzymes, and inhibition of reperfusi |
Jul. 24, 2001 |
| 6258804 |
Triazepinones, process for their preparation and their therapeutic application |
Jul. 10, 2001 |
| 6255350 |
Stabilized concentrates of water unstable AZA compounds and o/w miniemulsions thereof |
Jul. 3, 2001 |
| 6251885 |
Cytotrienins, process for preparing the same and anti-tumor agent |
Jun. 26, 2001 |
| 6251886 |
Methods of using temozolomide in the treatment of cancers |
Jun. 26, 2001 |
| 6251887 |
17.beta.-aryl(arylmethyl)oxy(thio)alkyl-androstane derivatives |
Jun. 26, 2001 |
| 6251948 |
Tri-and tetra-substituted guanidines and their use as excitatory amino acid antagonists |
Jun. 26, 2001 |
| 6245734 |
Physiologically active polyoxypeptin and deoxypolyoxypeptin and anticancer drugs containing the same |
Jun. 12, 2001 |
| 6245767 |
Monohydrates of aminobenzenesulfonic acid derivatives and method for preparing thereof |
Jun. 12, 2001 |
| 6239124 |
Pharmaceutical compositions for the treatment of transplant rejection or autoimmune or inflammatory conditions comprising cyclosporin A and 40-0-(2-hydroxyethyl)-rapamycin |
May. 29, 2001 |
| 6235747 |
6-phenyl-pyridin-2-ylamine derivatives |
May. 22, 2001 |
| 6232299 |
Use of protein kinase C inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy |
May. 15, 2001 |
| 6228986 |
Solid-phase synthesis of novel 14-membered macroycles for high throughput screening |
May. 8, 2001 |
| 6225050 |
Cyanine dyes as labeling reagents for detection of biological and other materials by luminescence methods |
May. 1, 2001 |
| 6225301 |
Therapeutic treatment for renal dysfunction |
May. 1, 2001 |
| 6225302 |
Amidino protease inhibitors |
May. 1, 2001 |
| 6225343 |
Compositions and methods comprising morphine gluconate |
May. 1, 2001 |
| 6221637 |
Xanthene derivatives, their production and use |
Apr. 24, 2001 |
| 6221858 |
Pyridyl-and pyrimidyl-piperazines in the treatment of substance abuse disorders |
Apr. 24, 2001 |
| 6221872 |
Pyrimidine derivatives and methods of making and using these derivatives |
Apr. 24, 2001 |
| 6214816 |
Heterocyclic compounds |
Apr. 10, 2001 |
| 6214817 |
Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity |
Apr. 10, 2001 |
| 6211175 |
Cardiac diseases improving method |
Apr. 3, 2001 |
| 6211203 |
Benzofuran-4-carboxamides |
Apr. 3, 2001 |
| 6207668 |
Substituted pyridines/pyrimidines, their preparation, and their use as pesticides |
Mar. 27, 2001 |
| 6200967 |
Anticoagulant agents |
Mar. 13, 2001 |
| 6201005 |
Method for inhibiting lymphokine production |
Mar. 13, 2001 |
| 6197781 |
Pharmaceutical compositions |
Mar. 6, 2001 |
| 6197830 |
Method for achieving relief from sympathetically mediated pain |
Mar. 6, 2001 |
| 6194401 |
Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of .alpha.-glycerophosphoric acid |
Feb. 27, 2001 |
| 6194412 |
Mixtures derived from grains of Eugenia Jambolana Lamarck preparation and use of said mixtures and some of their constituents as medicaments |
Feb. 27, 2001 |
| 6184223 |
Reverse-turn mimetics and methods relating thereto |
Feb. 6, 2001 |
| 6180619 |
Prenyl transferase inhibitors |
Jan. 30, 2001 |
| 6177419 |
Bipyridine manganese complexes |
Jan. 23, 2001 |
| 6177420 |
20-aralkyl-5.alpha.-pregnane derivatives |
Jan. 23, 2001 |
| 6174875 |
Benzoquinoid ansamycins for the treatment of cardiac arrest and stroke |
Jan. 16, 2001 |
| 6172117 |
Biocidal preservatives |
Jan. 9, 2001 |
| 6168808 |
Synergistic composition of peracetic acid and amine oxide |
Jan. 2, 2001 |
| 6169105 |
Potentiation of drug response |
Jan. 2, 2001 |
| 6165996 |
Compounds with chelation affinity selectivity for first transition series elements: use in medical therapy and diagnosis |
Dec. 26, 2000 |
| 6166003 |
Heterocyclic compounds for cancer chemoprevention |
Dec. 26, 2000 |
| 6166038 |
Aminopyrazole derivatives |
Dec. 26, 2000 |
| 6156744 |
DT-diaphorase directed anti-tumor agents |
Dec. 5, 2000 |
| 6150384 |
Pharmaceutical composition |
Nov. 21, 2000 |
| 6143739 |
Basic proline-amide derivatives of GE 2270 and GE 2270-like antibiotics |
Nov. 7, 2000 |
|
|
|
